LKLF and vascular responses to hemodynamic shear in vivo
LKLF 和血管对体内血流动力学剪切的反应
基本信息
- 批准号:7458614
- 负责人:
- 金额:$ 8.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-27 至 2009-01-12
- 项目状态:已结题
- 来源:
- 关键词:AdultAllelesAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAortaApolipoprotein EAreaArterial Fatty StreakAtherosclerosisBiologicalBiologyBlood VesselsBlood flowBos taurusCaliberCardiologyCattleCellsClinical ResearchCollaborationsConditionCore FacilityCultured CellsDevelopmentDoctor of MedicineElementsEmbryoEndothelial CellsEnvironmentFunctional disorderGene ExpressionGene TargetingHemorrhageHumanIndiumInflammationInternationalInvestigationLeadLesionLipidsLiquid substanceMechanicsMediatingMediator of activation proteinMentorshipMessenger RNAMolecularMolecular GeneticsMorphologyMusPathogenesisPathologicPatientsPennsylvaniaPhysiciansPhysiologicalPlayPredispositionPreventionProteinsResearchResearch PersonnelResearch TrainingRoleRuptureSamplingScientistSeveritiesSiteTestingThinkingTraining ProgramsTransfectionTunica MediaUniversitiesVascular Cell Adhesion Molecule-1Vascular DiseasesVascular Endotheliumcareerclinically significantcytokinedesignhemodynamicsin vivolung Kruppel-like factormature animalnovel therapeuticsprogramspromoterresearch studyresponsetherapeutic targettooltranscription factorvasculogenesis
项目摘要
DESCRIPTION (provided by applicant):
This proposal describes a 5-year research and training program designed to investigate how the vascular endothelium senses the local hemodynamic environment and mediates an adaptive or pathologic response. Clinical studies show that atherosclerotic lesions tend to develop in regions of the vasculature exposed to turbulent (low shear) blood flow. Regions of high shear tend to be protected. Elucidating how local hemodynamic conditions effect vascular biological responses may lead to important advances in the treatment and prevention of vascular diseases, such as, atherosclerosis. The central hypothesis of this proposal is that a recently discovered shear-responsive transcription factor, LKLF, plays a critical role in modulating the vascular response to hemodynamic shear. The specific aims outlined in this proposal will test this hypothesis by (1) confirming the shear-responsiveness of LKLF ex vivo and identifying shear-responsive elements in the LKLF promoter, (2) determining if LKLF is similarly regulated by hemodynamic shear in vivo, and (3) determining if loss of LKLF in murine adult vasculature causes loss of normal vascular function and increases susceptibility to and severity of atherosclerosis.
This research plan is also designed to provide the candidate with outstanding research training and mentorship during transition to a career of independent investigation as a physician-scientist. The training program will be supervised by Mark L. Kahn, M.D., in the Molecular Cardiology Research Center (MCRC) at the University of Pennsylvania. Dr. Kahn is an internationally recognized expert in vascular development and pathobiology. The MCRC, co-directed by Jonathon A. Epstein, M.D., and Michael S. Parmacek, M.D., Division Chief, offers extensive collaborative opportunities, core facilities, and intellectual expertise in nearly all aspects of vascular biology. Atherosclerosis studies will be performed in collaboration with Daniel S. Rader, M.D., an international leader in the field of lipid biology and pathogenesis of atherosclerosis.
描述(由申请人提供):
该建议描述了一项为期5年的研究和培训计划,旨在研究血管内皮如何感应局部血液动力学环境并介导适应性或病理反应。 临床研究表明,在暴露于湍流(低剪切)血液的脉管系统的区域中,动脉粥样硬化病变倾向于发展。高剪切的区域往往受到保护。 阐明局部血液动力学疾病如何影响血管生物学反应可能导致在治疗和预防血管疾病(例如动脉粥样硬化)方面的重要进展。 该提议的中心假设是最近发现的剪切响应转录因子LKLF在调节血管剪切的血管反应中起着至关重要的作用。 The specific aims outlined in this proposal will test this hypothesis by (1) confirming the shear-responsiveness of LKLF ex vivo and identifying shear-responsive elements in the LKLF promoter, (2) determining if LKLF is similarly regulated by hemodynamic shear in vivo, and (3) determining if loss of LKLF in murine adult vasculature causes loss of normal vascular功能并增加对动脉粥样硬化的敏感性和严重性。
该研究计划还旨在为候选人提供出色的研究培训和指导,以期过渡到独立调查的医生科学家。 该培训计划将由宾夕法尼亚大学分子心脏病学研究中心(MCRC)的马克·卡恩(Mark L. Kahn)监督。 Kahn博士是血管发展和病理学方面的国际认可的专家。 MCRC由M.D. Jonathon A. Epstein和M.D. M.D.的Michael S. Parmacek共同执导,在几乎所有方面的血管生物学方面都提供了广泛的合作机会,核心设施和知识专业知识。动脉粥样硬化研究将与丹尼尔·S·拉德(Daniel S.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN LEE其他文献
JOHN LEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN LEE', 18)}}的其他基金
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
新型血管活性肠肽缓释类似物 PB1046 在肺动脉高压患者中的安全性、耐受性和有效性
- 批准号:
9466673 - 财政年份:2018
- 资助金额:
$ 8.6万 - 项目类别:
Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
新型血管活性肠肽缓释类似物 PB1046 在肺动脉高压患者中的安全性、耐受性和有效性
- 批准号:
9753354 - 财政年份:2018
- 资助金额:
$ 8.6万 - 项目类别:
MECHANISMS OF IMMUNE CLEARANCE FOR HPV POSITIVE CELLS
HPV 阳性细胞的免疫清除机制
- 批准号:
8360654 - 财政年份:2011
- 资助金额:
$ 8.6万 - 项目类别:
LKLF and vascular responses to hemodynamic shear in vivo
LKLF 和血管对体内血流动力学剪切的反应
- 批准号:
6956755 - 财政年份:2005
- 资助金额:
$ 8.6万 - 项目类别:
LKLF and vascular responses to hemodynamic shear in vivo
LKLF 和血管对体内血流动力学剪切的反应
- 批准号:
7126747 - 财政年份:2005
- 资助金额:
$ 8.6万 - 项目类别:
LKLF and vascular responses to hemodynamic shear in vivo
LKLF 和血管对体内血流动力学剪切的反应
- 批准号:
7272746 - 财政年份:2005
- 资助金额:
$ 8.6万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis
研究长期潜伏的单纯疱疹病毒感染对 APOE4 相关阿尔茨海默病发病机制的作用
- 批准号:
10740641 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
- 批准号:
10750085 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Prenatal stress and diet, and the fetal epigenome
产前压力和饮食,以及胎儿表观基因组
- 批准号:
10523353 - 财政年份:2022
- 资助金额:
$ 8.6万 - 项目类别:
Identification of the specific risk allele responsible for oxidative stress in ARMS2/HTRA1-related AMD
鉴定导致 ARMS2/HTRA1 相关 AMD 氧化应激的特定风险等位基因
- 批准号:
10576542 - 财政年份:2022
- 资助金额:
$ 8.6万 - 项目类别: